Crossmark

Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation

Crossref DOI link: https://doi.org/10.1186/s12881-020-01173-0

Published Online: 2020-11-30

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Goubran, Mariam

Aderibigbe, Ayodeji

Jacquemin, Emmanuel

Guettier, Catherine

Girgis, Safwat

Bain, Vincent

Mason, Andrew L. https://orcid.org/0000-0002-0470-9522
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research

Canadian Liver Foundation
License Information

Text and Data Mining valid from 2020-11-30

Version of Record valid from 2020-11-30
More Information

Article History

Received: 25 July 2020

Accepted: 12 November 2020

First Online: 30 November 2020

Ethics approval and consent to participate

: Ethics approval was obtained from the University of Alberta, Human Research Ethics Board, Pro00005105. Written consent was obtained from the patient for sample collection and genetic analyses.

: The patient has provided informed written consent for publication.

: The authors declare no competing interests relevant to this publication.

Document is current

Any future updates will be listed below